Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,176–8,200 of 27,380 studies, newest first · page 328 of 1096.

December 2022 25

  1. 2022-12-17

    Cochlear Implants Now More Accessible to Older Adults

    ✓ Peer-reviewed Risk factors The Hearing Journal

    Key finding: Benefits Beyond Auditory Rehabilitation Research conducted by Frank Lin and colleagues found that individuals with untreated mild, moderate, and severe hearing loss had, respectively, a twofold, threefold, and fivefold increased risk of dementia compared with individuals with normal hearing. 4 Research suggests that early auditory rehabilitation is important for people of all ages, including older adults, as it can provide benefits and improvements beyond hearing ability such as cognitive function and mitigation of depression. +4 more findings

  2. 2022-12-16

    Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease

    ✓ Peer-reviewed Drug development Ageing research reviews

    Key finding: AD is a progressive age-related neurodegenerative disease most often associated with memory deficits and cognition that get more worsen over time. +1 more finding

  3. 2022-12-16

    Recent diagnostic techniques for the detection of Alzheimer's disease: a short review

    ✓ Peer-reviewed Biomarkers Irish journal of medical science

    Key finding: Dementia is characterized by the formation of senile plaques and neurofibrillary tangles, which is followed by neurotoxicity, which results in memory loss and mortality.

  4. 2022-12-16

    INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A non-coding variant (rs35349669) in INPP5D increases the risk for Alzheimer's disease (AD), and elevated INPP5D expression is associated with increased plaque deposition. +3 more findings

  5. 2022-12-15

    Evaluation of blood-based, extracellular vesicles as biomarkers for aging-related TDP-43 pathology

    ✓ Peer-reviewed Brain tissue and pathology Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: TDP-43 was significantly elevated in plasma ADEVs derived from autopsy confirmed LATE-NC subjects, with or without comorbid AD pathology. +3 more findings

  6. 2022-12-15

    Vascular contributions to Alzheimer's disease

    ✓ Peer-reviewed Vascular contributions Translational research : the journal of laboratory and clinical medicine

    Key finding: At neuroimaging, signs of vascular dysfunction such as chronic cerebral hypoperfusion have been demonstrated, appearing early in AD, even before cognitive decline and alteration of traditional biomarkers.

  7. 2022-12-15

    Speech biomarkers of risk factors for vascular dementia in people with mild cognitive impairment

    ✓ Peer-reviewed Risk factors Frontiers in human neuroscience

    Key finding: We found that some speech parameters of frequencies and syllabic rhythm vary due to these pathologies. +4 more findings

  8. 2022-12-15

    Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of clinical investigation

    Key finding: This study aimed to explore sTREM2 as a central and peripheral predictor of the conversion from mild cognitive impairment (MCI) to AD.METHODSsTREM2 and Aβ1-42 levels in cerebrospinal fluid (CSF) and florbetapir-PET (AV45) images were analyzed for healthy control (HCs), patients with MCI, and patients with AD from the ADNI database. +3 more findings

  9. 2022-12-14

    Plasma phosphorylated tau181 predicts cognitive and functional decline

    ✓ Peer-reviewed Biomarkers Annals of Clinical and Translational Neurology

    Key finding: Plasma p‐tau181 differentiated pathology‐confirmed AD from NC with negative amyloid PET scans with an AUC of 0.93. +4 more findings

  10. 2022-12-14

    SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex

    ✓ Peer-reviewed Drug development Acta neuropathologica communications

    Key finding: Thus, these novel results demonstrate that the function of αSyn on memory differs between male and female brains.

  11. 2022-12-14

    Role of Endogenous Lipopolysaccharides in Neurological Disorders

    ✓ Peer-reviewed Disease mechanisms Cells

    Key finding: An impaired BBB allows the translocation of potentially harmful bacterial products, including LPS, and activated neutrophils/leucocytes into the brain, which results in neuroinflammation and apoptosis.

  12. 2022-12-14
  13. 2022-12-14

    Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients

    ✓ Peer-reviewed Long-term cohort studies Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Baseline tau-PET and a composite baseline cognitive score were the strongest independent predictors of cognitive decline. +3 more findings

  14. 2022-12-14

    Therapeutic anti-amyloid β antibodies cause neuronal disturbances

    ✓ Peer-reviewed Drug development Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Recent published clinical trial safety data showed that 41% of Alzheimer patients experienced amyloid-related imaging abnormalities (ARIA), marks of microhemorrhages and edema in the brain, following administration of Biogen's Aduhelm/aducanumab (amino acids 3-7 of the Aβ peptide). +3 more findings

  15. 2022-12-14

    Models of microglia depletion and replenishment elicit protective effects to alleviate vascular and neuronal damage in the diabetic murine retina

    ✓ Peer-reviewed TREM2 and immune genetics Journal of neuroinflammation

    Key finding: Therefore, utilizing two models of microglia depletion, we aimed to deplete and repopulate microglia to clarify the contribution of microglia to neuronal loss and vascular damage in the diabetic retina in an STZ-induced model of hyperglycemia. +3 more findings

  16. 2022-12-14
  17. 2022-12-14

    Population-Based Estimates of 1-Year Mortality After Major Surgery Among Community-Living Older US Adults

    ✓ Peer-reviewed Disparities JAMA surgery

    Key finding: From 2011 to 2017, of the 1193 major surgeries (from 992 community-living participants), the mean (SD) age was 79.2 (7.1) years; 665 were women (55.7%), and 30 were Hispanic (2.5%), 198 non-Hispanic Black (16.6%), and 915 non-Hispanic White (76.7%).

  18. 2022-12-14
  19. 2022-12-13

    LATE-NC staging in routine neuropathologic diagnosis: an update

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica

    Key finding: Neuroanatomical regions of interest in LATE-NC are described in detail and the implications for TDP-43 immunohistochemical results are specified more precisely.

  20. 2022-12-13

    Synaptic degeneration in Alzheimer disease

    ✓ Peer-reviewed Disease mechanisms Nature reviews. Neurology

    Key finding: The disease results in brain atrophy caused by neuronal loss and synapse degeneration. +1 more finding

  21. 2022-12-12

    From degenerative disease to malignant tumors: Insight to the function of ApoE

    ✓ Peer-reviewed Genetics Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    Key finding: Due to genetic polymorphisms of ApoE (ε2, ε3, and ε4), its three common structural isoforms (ApoE2, ApoE3, ApoE4) are also associated with the risk of many diseases, especially degenerative diseases, such as vascular degenerative diseases including atherosclerosis (AS), coronary heart disease (CHD), and neurodegenerative disease like Alzheimer's disease (AD). +1 more finding

  22. 2022-12-12

    Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Our study indicates that changes in PVS-related MRI parameters occur in MCI and AD, possibly due to impairment of the glymphatic system. +2 more findings

  23. 2022-12-10
  24. 2022-12-09

    Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons

    ✓ Peer-reviewed Inflammation and the immune system Acta neuropathologica

    Key finding: In CA1, NLRP3-positive microglia and cleaved GSDMD-positive neurons were associated with local neuronal loss, indicating a possible contribution of NLRP3 inflammasome and pyroptosis activation to AD-related neurodegeneration. +1 more finding

  25. 2022-12-08

    Causal association between systemic lupus erythematosus and the risk of dementia: A Mendelian randomization study

    ✓ Peer-reviewed Genetics Frontiers in immunology

    Key finding: No significant causal association was found between SLE and any type of dementia, including Alzheimer's disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies. +2 more findings

Browse the library by subject, with the full score breakdown →